Human herpesvirus‐6 encephalitis following chemotherapy induction for acute myelogenous leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|19|6|tid.12756-tid.12756

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.19, Iss.6, 2017-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Myelogenous Leukemia in the Elderly

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 3, 1992-03 ,pp. : 277-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

By  

Acta Haematologica, Vol. 134, Iss. 1, 2015-04 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome

By AbuTarif M.A.   Krishna G.   Statkevich P.  

Current Medical Research and Opinion, Vol. 26, Iss. 2, 2010-02 ,pp. : 397-405

Informa Healthcare

Access to resources Recommend Favorite

Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 773-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 55-64

Karger

Access to resources Recommend Favorite